市場調查報告書

新型冠狀病毒感染疾病 (COVID-19) 診斷:全球市場的展望(2018-2027年)

COVID-19 Diagnostics - Global Market Outlook (2018-2027)

出版商 Stratistics Market Research Consulting 商品編碼 939154
出版日期 內容資訊 英文 140 Pages
商品交期: 2-3個工作天內
價格
新型冠狀病毒感染疾病 (COVID-19) 診斷:全球市場的展望(2018-2027年) COVID-19 Diagnostics - Global Market Outlook (2018-2027)
出版日期: 2020年05月01日內容資訊: 英文 140 Pages
簡介

全球新型冠狀病毒感染疾病 (COVID-19) 診斷市場在預測期間內預計將以7.6%的年複合成長率推移,從2018年的161億3000萬美元,成長到2027年311億8000萬美元的規模。全球性感染者數的增加,正確檢驗結果的需求促進了市場的成長。但是,對冠狀病毒,其症狀和傳染性的了解不足限制了市場的進一步增長。

本報告提供全球新型冠狀病毒感染疾病 (COVID-19) 診斷的市場調查,彙整市場及產品概要,市場成長的各種影響因素及市場機會分析,用戶數·檢驗類型·終端用戶·地區/主要國家等各種區分趨勢與市場規模的變化與預測,競爭環境,主要企業簡介等資訊。

第1章 摘要整理

第2章 序文

第3章 市場趨勢分析

  • 簡介
  • 促進因素
  • 阻礙因素
  • 市場機會
  • 威脅
  • 終端用戶分析
  • 新興市場
  • Covid-19的影響

第4章 波特的五力分析

第5章 全球 COVID-19診斷市場:各用戶數

  • 簡介
  • 複數
  • 單數

第6章 全球 COVID-19診斷市場:各檢驗類型

  • 簡介
  • 血清檢驗
  • 分子學的檢驗

第7章 全球 COVID-19診斷市場:各終端用戶

  • 簡介
  • 公共衛生研究所
  • 民間·商業實驗室
  • 醫生實驗室
  • 醫院

第8章 全球 COVID-19診斷市場: 各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第9章 主要展開

  • 契約·聯盟·合作·JV
  • M&A
  • 新產品的銷售
  • 擴張
  • 其他主要策略

第10章 企業簡介

  • Alveo Technologies
  • Accelerate Diagnostics
  • Abbott Diagnostics
  • Aus Diagnostics
  • Ador Diagnostics
  • Akkoni Biosystems
  • Applied BioCode
  • BD Diagnostics
  • Cue Health
  • Biocartis
  • Co-Diagnostics
  • BioFire Diagnostics
  • Cepheid
  • bioMerieux
  • Bosch Healthcare Solutions GmbH
  • Bio-Rad Laboratories
  • Curetis
  • GenePOC Diagnostics
  • Diagenode Diagnostics
  • GenMark Dx
目錄

According to Stratistics MRC, the Global COVID-19 Diagnostics Market is accounted for $16.13 billion in 2018 and is expected to reach $31.18 billion by 2027 growing at a CAGR of 7.6% during the forecast period. Rise in number of cases of COVID-19 patients across the globe and requirement to ensure accurate test results are the major factors driving the market growth. However, lack of knowledge about corona virus, its symptoms, and its ability to spread is restraining the market growth.

COVID-19 is an infectious disease caused due to Corona virus. Its symptoms include mild to moderate respiratory discomfort. While most may recover without any need for special treatment, the virus can cause major issues or serious illness and even death in older individuals and persons with underlying medical problems such as diabetes and cancers. As it have been the cause of numerous deaths, and infections in the past there is a urgent need for accurate diagnostic methods.

Based on test type, the molecular segment is likely to have a huge demand as it involves the extraction of viral RNA from a patient's sample and synthesis of the complementary DNA (cDNA) followed by amplification of the viral genome. By geography, North America is going to have a lucrative growth during the forecast period due to the well-established healthcare system and several pharmaceutical companies.

Some of the key players profiled in the COVID-19 Diagnostics Market include Alveo Technologies, Accelerate Diagnostics, Abbott Diagnostics, Aus Diagnostics, Ador Diagnostics, Akkoni Biosystems , Applied BioCode, BD Diagnostics, Cue Health, Biocartis, Co-Diagnostics , BioFire Diagnostics, Cepheid, bioMerieux, Bosch Healthcare Solutions GmbH, Bio-Rad Laboratories , Curetis, GenePOC Diagnostics , Diagenode Diagnostics and GenMark Dx.

Quantity of Users Covered:

  • Multiple
  • Single

Test Types Covered:

  • Serology
  • Molecular

End Users Covered:

  • Public Health Labs
  • Private or Commercial Labs
  • Physician Labs
  • Hospitals

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis, etc.
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking

Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global COVID-19 Diagnostics Market, By Quantity of User

  • 5.1 Introduction
  • 5.2 Multiple
  • 5.3 Single

6 Global COVID-19 Diagnostics Market, By Test Type

  • 6.1 Introduction
  • 6.2 Serology
  • 6.3 Molecular

7 Global COVID-19 Diagnostics Market, By End User

  • 7.1 Introduction
  • 7.2 Public Health Labs
  • 7.3 Private or Commercial Labs
  • 7.4 Physician Labs
  • 7.5 Hospitals

8 Global COVID-19 Diagnostics Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Alveo Technologies
  • 10.2 Accelerate Diagnostics
  • 10.3 Abbott Diagnostics
  • 10.4 Aus Diagnostics
  • 10.5 Ador Diagnostics
  • 10.6 Akkoni Biosystems
  • 10.7 Applied BioCode
  • 10.8 BD Diagnostics
  • 10.9 Cue Health
  • 10.10 Biocartis
  • 10.11 Co-Diagnostics
  • 10.12 BioFire Diagnostics
  • 10.13 Cepheid
  • 10.14 bioMerieux
  • 10.15 Bosch Healthcare Solutions GmbH
  • 10.16 Bio-Rad Laboratories
  • 10.17 Curetis
  • 10.18 GenePOC Diagnostics
  • 10.19 Diagenode Diagnostics
  • 10.20 GenMark Dx

List of Tables

  • Table 1 Global COVID-19 Diagnostics Market Outlook, By Region (2017-2027) ($MN)
  • Table 2 Global COVID-19 Diagnostics Market Outlook, By Quantity of User (2017-2027) ($MN)
  • Table 3 Global COVID-19 Diagnostics Market Outlook, By Multiple (2017-2027) ($MN)
  • Table 4 Global COVID-19 Diagnostics Market Outlook, By Single (2017-2027) ($MN)
  • Table 5 Global COVID-19 Diagnostics Market Outlook, By Test Type (2017-2027) ($MN)
  • Table 6 Global COVID-19 Diagnostics Market Outlook, By Serology (2017-2027) ($MN)
  • Table 7 Global COVID-19 Diagnostics Market Outlook, By Molecular (2017-2027) ($MN)
  • Table 8 Global COVID-19 Diagnostics Market Outlook, By End User (2017-2027) ($MN)
  • Table 9 Global COVID-19 Diagnostics Market Outlook, By Public Health Labs (2017-2027) ($MN)
  • Table 10 Global COVID-19 Diagnostics Market Outlook, By Private or Commercial Labs (2017-2027) ($MN)
  • Table 11 Global COVID-19 Diagnostics Market Outlook, By Physician Labs (2017-2027) ($MN)
  • Table 12 Global COVID-19 Diagnostics Market Outlook, By Hospitals (2017-2027) ($MN)
  • Table 13 North America COVID-19 Diagnostics Market Outlook, By Country (2017-2027) ($MN)
  • Table 14 North America COVID-19 Diagnostics Market Outlook, By Quantity of User (2017-2027) ($MN)
  • Table 15 North America COVID-19 Diagnostics Market Outlook, By Multiple (2017-2027) ($MN)
  • Table 16 North America COVID-19 Diagnostics Market Outlook, By Single (2017-2027) ($MN)
  • Table 17 North America COVID-19 Diagnostics Market Outlook, By Test Type (2017-2027) ($MN)
  • Table 18 North America COVID-19 Diagnostics Market Outlook, By Serology (2017-2027) ($MN)
  • Table 19 North America COVID-19 Diagnostics Market Outlook, By Molecular (2017-2027) ($MN)
  • Table 20 North America COVID-19 Diagnostics Market Outlook, By End User (2017-2027) ($MN)
  • Table 21 North America COVID-19 Diagnostics Market Outlook, By Public Health Labs (2017-2027) ($MN)
  • Table 22 North America COVID-19 Diagnostics Market Outlook, By Private or Commercial Labs (2017-2027) ($MN)
  • Table 23 North America COVID-19 Diagnostics Market Outlook, By Physician Labs (2017-2027) ($MN)
  • Table 24 North America COVID-19 Diagnostics Market Outlook, By Hospitals (2017-2027) ($MN)
  • Table 25 Europe COVID-19 Diagnostics Market Outlook, By Country (2017-2027) ($MN)
  • Table 26 Europe COVID-19 Diagnostics Market Outlook, By Quantity of User (2017-2027) ($MN)
  • Table 27 Europe COVID-19 Diagnostics Market Outlook, By Multiple (2017-2027) ($MN)
  • Table 28 Europe COVID-19 Diagnostics Market Outlook, By Single (2017-2027) ($MN)
  • Table 29 Europe COVID-19 Diagnostics Market Outlook, By Test Type (2017-2027) ($MN)
  • Table 30 Europe COVID-19 Diagnostics Market Outlook, By Serology (2017-2027) ($MN)
  • Table 31 Europe COVID-19 Diagnostics Market Outlook, By Molecular (2017-2027) ($MN)
  • Table 32 Europe COVID-19 Diagnostics Market Outlook, By End User (2017-2027) ($MN)
  • Table 33 Europe COVID-19 Diagnostics Market Outlook, By Public Health Labs (2017-2027) ($MN)
  • Table 34 Europe COVID-19 Diagnostics Market Outlook, By Private or Commercial Labs (2017-2027) ($MN)
  • Table 35 Europe COVID-19 Diagnostics Market Outlook, By Physician Labs (2017-2027) ($MN)
  • Table 36 Europe COVID-19 Diagnostics Market Outlook, By Hospitals (2017-2027) ($MN)
  • Table 37 Asia Pacific COVID-19 Diagnostics Market Outlook, By Country (2017-2027) ($MN)
  • Table 38 Asia Pacific COVID-19 Diagnostics Market Outlook, By Quantity of User (2017-2027) ($MN)
  • Table 39 Asia Pacific COVID-19 Diagnostics Market Outlook, By Multiple (2017-2027) ($MN)
  • Table 40 Asia Pacific COVID-19 Diagnostics Market Outlook, By Single (2017-2027) ($MN)
  • Table 41 Asia Pacific COVID-19 Diagnostics Market Outlook, By Test Type (2017-2027) ($MN)
  • Table 42 Asia Pacific COVID-19 Diagnostics Market Outlook, By Serology (2017-2027) ($MN)
  • Table 43 Asia Pacific COVID-19 Diagnostics Market Outlook, By Molecular (2017-2027) ($MN)
  • Table 44 Asia Pacific COVID-19 Diagnostics Market Outlook, By End User (2017-2027) ($MN)
  • Table 45 Asia Pacific COVID-19 Diagnostics Market Outlook, By Public Health Labs (2017-2027) ($MN)
  • Table 46 Asia Pacific COVID-19 Diagnostics Market Outlook, By Private or Commercial Labs (2017-2027) ($MN)
  • Table 47 Asia Pacific COVID-19 Diagnostics Market Outlook, By Physician Labs (2017-2027) ($MN)
  • Table 48 Asia Pacific COVID-19 Diagnostics Market Outlook, By Hospitals (2017-2027) ($MN)
  • Table 49 South America COVID-19 Diagnostics Market Outlook, By Country (2017-2027) ($MN)
  • Table 50 South America COVID-19 Diagnostics Market Outlook, By Quantity of User (2017-2027) ($MN)
  • Table 51 South America COVID-19 Diagnostics Market Outlook, By Multiple (2017-2027) ($MN)
  • Table 52 South America COVID-19 Diagnostics Market Outlook, By Single (2017-2027) ($MN)
  • Table 53 South America COVID-19 Diagnostics Market Outlook, By Test Type (2017-2027) ($MN)
  • Table 54 South America COVID-19 Diagnostics Market Outlook, By Serology (2017-2027) ($MN)
  • Table 55 South America COVID-19 Diagnostics Market Outlook, By Molecular (2017-2027) ($MN)
  • Table 56 South America COVID-19 Diagnostics Market Outlook, By End User (2017-2027) ($MN)
  • Table 57 South America COVID-19 Diagnostics Market Outlook, By Public Health Labs (2017-2027) ($MN)
  • Table 58 South America COVID-19 Diagnostics Market Outlook, By Private or Commercial Labs (2017-2027) ($MN)
  • Table 59 South America COVID-19 Diagnostics Market Outlook, By Physician Labs (2017-2027) ($MN)
  • Table 60 South America COVID-19 Diagnostics Market Outlook, By Hospitals (2017-2027) ($MN)
  • Table 61 Middle East & Africa COVID-19 Diagnostics Market Outlook, By Country (2017-2027) ($MN)
  • Table 62 Middle East & Africa COVID-19 Diagnostics Market Outlook, By Quantity of User (2017-2027) ($MN)
  • Table 63 Middle East & Africa COVID-19 Diagnostics Market Outlook, By Multiple (2017-2027) ($MN)
  • Table 64 Middle East & Africa COVID-19 Diagnostics Market Outlook, By Single (2017-2027) ($MN)
  • Table 65 Middle East & Africa COVID-19 Diagnostics Market Outlook, By Test Type (2017-2027) ($MN)
  • Table 66 Middle East & Africa COVID-19 Diagnostics Market Outlook, By Serology (2017-2027) ($MN)
  • Table 67 Middle East & Africa COVID-19 Diagnostics Market Outlook, By Molecular (2017-2027) ($MN)
  • Table 68 Middle East & Africa COVID-19 Diagnostics Market Outlook, By End User (2017-2027) ($MN)
  • Table 69 Middle East & Africa COVID-19 Diagnostics Market Outlook, By Public Health Labs (2017-2027) ($MN)
  • Table 70 Middle East & Africa COVID-19 Diagnostics Market Outlook, By Private or Commercial Labs (2017-2027) ($MN)
  • Table 71 Middle East & Africa COVID-19 Diagnostics Market Outlook, By Physician Labs (2017-2027) ($MN)
  • Table 72 Middle East & Africa COVID-19 Diagnostics Market Outlook, By Hospitals (2017-2027) ($MN)